Honoring outstanding achievements
Ten people ranging in age from 37 to 46 have been honored with outstanding achievement awards.
They include Pu Huayan, 37, the engineer who designed unmanned vessels used for polar science research, and electronic circuits expert Da Shengwei, 46, whose company plays a leading global role in the fields of deep learning and computer vision algorithms.
Another winner, 45-year-old Li Zonghai, has led the world in the study of using cutting-edge CAR-T therapy for cancer patients.
鈥淚 hope to make cancer curable,鈥 he said.
In many cases, cancer patients are diagnosed too late to receive surgery, and they have to turn to other approaches.
However, chemotherapy kills everything and severely damages the immune system. Expensive targeted drugs don鈥檛 work beyond extending life for several weeks to several months.
Even emerging radiation therapies, such as heavy ion therapy, can work on just a very few cancers in limited areas. 鈥淪o, patients just end up losing money and life,鈥 said Li.
Immunotherapy, represented by CAR-T, became a hot topic after 2010.
Chimeric antigen receptor T-cell therapy uses genetically engineered T cells 鈥 a type of white blood cells that act as 鈥渟pecial forces鈥 in the body and are equipped with artificial receptors that allow them to better recognize cancer cells. Li鈥檚 company, CARsgen Therapeutics, cooperated with Shanghai鈥檚 Renji Hospital to try the therapy on two advanced liver cancer patients.
Researchers used T cells from blood samples, genetically engineered them in the lab and then injected them back into the patients.
鈥淚t required about 17 days of treatment,鈥 said Li. 鈥淭he patients鈥 cancers have apparently been eradicated. They have lived cancer-free for more than three years.鈥
Li said he hopes to develop medicine based on the therapy so that more cancer patients can benefit from the treatment.
Li鈥檚 company, with offices in China and the US, has been given the green light to launch clinical research on five CAR-T projects targeting liver cancer, myeloma and leukemia. Three are being tried on human beings for the first time.
鈥淚n the study of cutting-edge technologies, China is fully capable of rivaling the United States,鈥 Li said. 鈥淔or us, favorable policies greatly matter.鈥
- About Us
- |
- Terms of Use
- |
-
RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔$粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.